Bolt Biotherapeutics, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Bolt Biotherapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2020 to Q2 2024.
  • Bolt Biotherapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $2.83M, a 20.2% increase year-over-year.
  • Bolt Biotherapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $9.52M, a 4.75% increase year-over-year.
  • Bolt Biotherapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $9.22M, a 3.69% decline from 2022.
  • Bolt Biotherapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $9.58M, a 12.7% increase from 2021.
  • Bolt Biotherapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $8.5M, a 499% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $9.52M $2.83M +$475K +20.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $9.05M $2.3M -$174K -7.03% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $9.22M $2.07M -$55K -2.59% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-21
Q3 2023 $9.28M $2.33M +$186K +8.68% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $9.09M $2.35M -$41K -1.72% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $9.13M $2.48M -$443K -15.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $9.58M $2.12M -$19K -0.89% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-21
Q3 2022 $9.6M $2.14M -$83K -3.73% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $9.68M $2.39M +$368K +18.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 $9.31M $2.92M +$810K +38.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $8.5M $2.14M +$1.57M +276% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-29
Q3 2021 $6.93M $2.23M +$1.82M +452% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $5.1M $2.02M +$1.8M +807% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 $3.3M $2.11M +$1.88M +837% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $1.42M $569K Oct 1, 2020 Dec 31, 2020 10-K 2022-03-30
Q3 2020 $403K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $223K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $225K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.